Profile
Nextech Venture is a venture capital firm based in Zurich, Switzerland, founded in 1998. The firm focuses on investing in life sciences, high tech, and consumer sectors. Nextech Venture has a history of successful investments, with a portfolio that includes companies that have gone public or been acquired. The firm is known for its strategic partnerships and co-investments with other major funds.
Nextech Venture primarily invests in Series D rounds, with a focus on United States-based startups. The firm has participated in notable funding rounds, including the Series C round of Alumis. Nextech Venture's investment strategy spans a wide range of sectors, emphasizing life sciences and high tech. The firm collaborates with partners like HBM Healthcare Investments to enhance its investment reach.
Notable investments by Nextech Venture include Alumis - a biopharmaceutical company, MacroGenics - a clinical-stage biopharmaceutical company, and Ganymed Pharmaceuticals - a biotechnology company. These investments highlight the firm's focus on innovative companies in the life sciences sector.
Industry
Contacts
Instant access on the web. Plans from $129/month — see pricing.